| Product Code: ETC9971246 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Needle Biopsy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Needle Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Needle Biopsy Market - Industry Life Cycle |
3.4 United States (US) Needle Biopsy Market - Porter's Five Forces |
3.5 United States (US) Needle Biopsy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Needle Biopsy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Needle Biopsy Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United States (US) Needle Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the United States, leading to a higher demand for needle biopsy procedures. |
4.2.2 Technological advancements in needle biopsy techniques, making the procedures more accurate and less invasive. |
4.2.3 Growing awareness among healthcare professionals and patients about the benefits of early cancer detection through needle biopsies. |
4.3 Market Restraints |
4.3.1 High cost associated with needle biopsy procedures, limiting access for some patient populations. |
4.3.2 Regulatory challenges and compliance issues related to needle biopsy practices. |
4.3.3 Limited reimbursement policies for needle biopsy procedures, impacting the adoption rate. |
5 United States (US) Needle Biopsy Market Trends |
6 United States (US) Needle Biopsy Market, By Types |
6.1 United States (US) Needle Biopsy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Needle Biopsy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Needle Biopsy Market Revenues & Volume, By Fine-needle Aspiration Biopsy, 2021- 2031F |
6.1.4 United States (US) Needle Biopsy Market Revenues & Volume, By Core Needle Biopsy, 2021- 2031F |
6.2 United States (US) Needle Biopsy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Needle Biopsy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 United States (US) Needle Biopsy Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F |
6.2.4 United States (US) Needle Biopsy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 United States (US) Needle Biopsy Market Revenues & Volume, By Transperineal, 2021- 2031F |
6.2.6 United States (US) Needle Biopsy Market Revenues & Volume, By Transcrectal, 2021- 2031F |
6.2.7 United States (US) Needle Biopsy Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.3 United States (US) Needle Biopsy Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Needle Biopsy Market Revenues & Volume, By Hospital, 2021- 2031F |
6.3.3 United States (US) Needle Biopsy Market Revenues & Volume, By Diagnostics & Imaging Centers, 2021- 2031F |
6.3.4 United States (US) Needle Biopsy Market Revenues & Volume, By Research Laboratories & Academic Institutes, 2021- 2031F |
6.3.5 United States (US) Needle Biopsy Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Needle Biopsy Market Import-Export Trade Statistics |
7.1 United States (US) Needle Biopsy Market Export to Major Countries |
7.2 United States (US) Needle Biopsy Market Imports from Major Countries |
8 United States (US) Needle Biopsy Market Key Performance Indicators |
8.1 Average waiting time for needle biopsy appointments. |
8.2 Rate of adoption of advanced needle biopsy technologies. |
8.3 Patient satisfaction scores related to their needle biopsy experience. |
9 United States (US) Needle Biopsy Market - Opportunity Assessment |
9.1 United States (US) Needle Biopsy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Needle Biopsy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Needle Biopsy Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United States (US) Needle Biopsy Market - Competitive Landscape |
10.1 United States (US) Needle Biopsy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Needle Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here